文献速递肝病

肝硬化住院患者院内感染频繁且负面影响结局

Nosocomial Infections Are Frequent and Negatively Impact Outcomes in Hospitalized Patients With Cirrhosis.
PubMed 文献 · Am J Gastroenterol · 2019-01-01

北美终末期肝病研究联盟纳入2864例非择期入院的肝硬化患者,15%(n=436)发生院内感染(NI)。NI与慢加急性肝衰竭、死亡和移植率升高相关,且独立于入院感染状态;入院感染、MELD>20、SIRS标准、PPI、利福昔明和乳果糖使用为NI风险因素,但回归模型不稳健。

要点

  • 肝硬化住院患者中15%发生院内感染,NI与不良结局相关。
  • NI患者慢加急性肝衰竭、死亡和移植率更高,无论是否合并入院感染。
  • 入院感染、MELD>20、SIRS、PPI、利福昔明和乳果糖使用与NI风险相关,但模型不稳健。

核心结论

  • 院内感染在肝硬化住院患者中普遍存在,且与不良结局相关。

研究设计与样本

  • 北美终末期肝病研究联盟(NACSELD)多中心队列研究,纳入2864例非择期入院的肝硬化患者,比较有无NI患者的入院变量和30天结局。

主要发现

  • 2864例中15%(n=436)发生NI;1866例无感染,562例仅有入院感染,228例仅有NI,208例两者均有。
  • NI患者较无NI患者更易发生急性-on-慢性肝衰竭、死亡和移植,且不依赖于入院感染。
  • NI患者较无NI患者呼吸系统感染、尿路感染、艰难梭菌感染、真菌感染和耐万古霉素肠球菌感染率更高。
  • NI风险因素包括入院感染、MELD>20、SIRS标准、PPI、利福昔明和乳果糖使用,但回归模型敏感性0.67、特异性0.63,不稳健。
  • 年龄、酒精病因、入院MELD评分、乳果糖使用、ACLF、急性肾损伤、ICU和NI增加死亡风险,而利福昔明降低死亡风险。

临床怎么用

  • 所有肝硬化住院患者均需保持警惕并采取预防策略。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Nosocomial infections (NIs) can be a major cause of morbidity and mortality in cirrhosis. This study aims to define the determinants of NI development and its impact on 30-day outcomes among hospitalized patients with cirrhosis. METHODS: North American Consortium for the Study of End-Stage Liver Disease enrolled patients with cirrhosis who were admitted nonelectively. Admission variables and 30-day outcomes were compared between patients with and without NI. These were also compared based on whether there was an isolated admission infection, NI, or both. Models were created for NI development using admission variables and for 30-day mortality. RESULTS: The study included 2,864 patients; of which, 15% (n = 436) developed NI. When comparing NI vs no NI, 1,866 patients were found to be infection free, whereas 562 had admission infections only, 228 had only NI, and 208 had both infections. At admission, patients with NI were more likely to be infected and have advanced cirrhosis. NIs were associated with higher rates of acute-on-chronic liver failure, death, and transplant regardless of admission infections. Patients with NI had higher respiratory infection, urinary tract infection, Clostridium difficile infection, fungal infections, and infection with vancomycin-resistant enterococci compared with patients without NI. Risk factors for NIs were admission infections, model for end-stage liver disease (MELD) > 20, systemic inflammatory response syndrome criteria, proton pump inhibitor, rifaximin, and lactulose use, but the regression model (sensitivity, 0.67; specificity, 0.63) was not robust. Age, alcohol etiology, admission MELD score, lactulose use, acute-on-chronic liver failure, acute kidney injury, intensive care unit, and NI increased the risk of death, whereas rifaximin decreased the risk of death. DISCUSSION: NIs are prevalent in hospitalized patients with cirrhosis and are associated with poor outcomes. Although higher MELD scores and systemic inflammatory response syndrome are associated with NI, all hospitalized patients with cirrhosis require vigilance and preventive strategies.

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Bajaj JS, OʼLeary JG, Tandon P, et al. Nosocomial Infections Are Frequent and Negatively Impact Outcomes in Hospitalized Patients With Cirrhosis. Am J Gastroenterol. 2019. PMID: 31180922. doi:10.14309/ajg.0000000000000280

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。